跳至主要内容
临床试验/NCT04604483
NCT04604483尚未招募不适用

Percutaneous Tibial Nerve Stimulation for Chronic Anal Fissure - a Prospective Study

Region Skane2 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2024年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
Region Skane
入组人数
52
试验地点
2
主要终点
Healing rate

研究概览

简要总结

Chronic anal fissure rarely heals spontaneously. About 50% heal on administration om topical muscle relaxants (e.g. diltiazem) and/or injection of Botulinum toxin, but for the remainder of patients surgery (with lateral internal sphincterotomy or fissurectomy) with subsequent risks of anal incontinence has been the golden standard. Treatment with PTNS (percutaneous tibial nerve stimulation) has been showed to produce healing of chronic anal fissures not responding to topical treatment, thus avoiding the risk for debilitating anal incontinence.

详细描述

This study will prospectively include 52 patients with chronic anal fissure that have received topical treatment and stool softeners and have all been evaluated by experienced proctological surgeons. The treatment will be given for 10 consecutive work days and then evaluated at 3 and 12 months. If the patients symptoms are unimproved at 3 months alternative treatments will be offered.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Verified anal fissure (Clinical assessement by experienced proctological surgeon)
  • Full conservative treatment has been given

排除标准

  • Inflammatory bowel disease
  • Fistula and/or anal abscess
  • Patients with compromised immunity
  • Pregnancy
  • Treatment with anti-coagulants (not aspirin)
  • Previous irradiation towards pelvic floor
  • Pacemaker or implanted defibrillator

研究组 & 干预措施

PTNS

Experimental

Treatment with PTNS for chronic anal fissure, treatment to be given for 30 minutes during 10 consecutive work Days.

干预措施: PTNS (Device)

结局指标

主要结局

Healing rate

时间窗: 12 months after treatment

Healing of anal fissure from assessement of clinical and/or data from patient form

次要结局

  • Adverse effects(12 months after treatment)
  • Smoking(12 months after treatment)
  • Bowel movements(12 months after treatment)

研究者

发起方
Region Skane
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验